Age-related macular disease (ARMD) is a degenerative disease of the macula, most common over the age of 50 years.
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Age-related maculopathy (ARM) is a disorder of the macular area most apparent after age 50 and is characterised by the following:
• Areas of drusen which are external to the neuroretina and retinal pigment epithelium (RPE). They are soft and distinct or soft and indistinct. Hard drusen are not characteristic of ARM. Drusen are discrete white-yellow spots containing abnormal extracellular lipoprotein deposits that accumulate between the RPE basal lamina and the inner collagenous layer of Bruch's membrane. 7 • Hyperpigmentation in the outer retina or choroid with drusen.
• Hypopigmentation of the RPE with drusen.
This early stage of the condition may not affect vision, but can predispose patients to visual loss (see Figure 1 ).
Later stages of the condition are classified as 'wet' or 'dry' age-related macular degeneration (AMD). These forms of the disease can occur with or without the involvement of new blood vessel growth. If new vessels are not involved (dry AMD), clinical presentation is a sharply defined round or oval area of hypopigmentation where choroidal vessels are more visible than the surrounding area, with a diameter greater than 175 μm 1 (see Figure 2 ). This is also known as geographic atrophy (GA).
The term 'wet AMD', also known as disciform AMD, exudative AMD or neovascular AMD refers to the development of choroidal neovascularisation (see Figure 3 ) and has numerous manifestations, including:
• choroidal neovascularisation (CNV);
• RPE detachment(s);
• subretinal or sub-RPE neovascular membrane(s);
• deposition of scarring, glial tissue or fibrin-like material within the epiretinal, intraretinal, subretinal or sub-RPE layers;
• subretinal haemorrhages (without other retinal vascular cause); and
• hard exudates (formed from lipid) associated with the above manifestations (without other retinal vascular cause).
This article uses the terms ARM, AMD and ARMD as per the international classification system described.
Physiology of Age-related Macular Disease
The RPE rests on Bruch's membrane and separates the neural retina from the choriocapillaris. The RPE phagocytoses the outer segment discs of the photoreceptors and is a point of metabolite and waste exchange, which is considered crucial to retinal function. 8 The initial signs of ARMD are variations within and below the RPE, seen as alterations in the pigmentation of the RPE, with or without the occurrence of drusen. 9 Drusen are discrete white-yellow spots containing abnormal extracellular lipoprotein deposits that accumulate between the RPE basal lamina and the inner collagenous layer of Bruch's membrane. 7 Within the ageing eye a build up of lipofuscin granules can be seen in the RPE, 10 possibly caused by a reduced ability of the RPE's phagocytic-lysosomal system to efficiently digest photoreceptor outer segment membranes, 11 leading to an accumulation of lipids from this material in Bruch's membrane reducing membrane permeability. This in turn may interrupt the supply of nutrients from the choroid to the retina ultimately leading to photoreceptor atrophy. 12 Oxidative stress causes injury and inflammation to the RPE and choriocapillaris which may lead to an altered extracellular matrix. This affects nutrient supply to the RPE and retina, possibly thus further damaging the RPE and retina, leading to the retinal atrophy seen in the later stages of ARMD.
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Aetiology of Age-related Macular Disease
Although the precise aetiology of ARMD is currently unknown, there are several hypotheses that have been postulated.
Oxidative Stress
Ageing is associated with cumulative oxidative damage. 14 [42] [43] [44] More may be learnt over time as genetic marker testing becomes
Posterior Segment Age-related Macular Degeneration 58, 59 and fluid diffusion is slowed. 46 It is thought that the debris within Bruch's membrane is derived from RPE metabolic activity 58 and this rise in lipid and protein quantity within Bruch's membrane reduces permeability, thus impeding flow of macromolecules between the RPE and choroid. 60 This may lead to slowed regeneration of photopigment due to retinoid deficiency, ultimately causing photoreceptor loss. 61 Bruch's membrane thickens with increasing age, 62 which is associated with a decline in phagocytosis of photoreceptor outer segments by RPE cells 63 and increases the distance for oxygen transport between the choriocapillaris and outer retina, reducing the oxygen to the outer retina. 64 In the normally functioning RPE, angiogenic growth factors such as vascular endothelial growth factor (VEGF) and anti-angiogenic factors like pigment-epithelium derived factor are optimally balanced within the RPE. Oxidative stress and the accumulation of deposits within the RPE and Bruch's membrane may disrupt this balance 65, 66 upregulating VEGF, which increases vascular permeability and angiogenesis, contributing to the development of CNV. [67] [68] [69] There is evidence that choroidal circulation attenuation may be responsible for development of ARMD. Ninety per cent of the oxygen requirement of the photoreceptors is provided by the choroidal circulation 70 and reduced choroidal blood flow has been associated with ARMD. 71, 72 Choriocapillaris density and lumen diameter reduce with age, 73 which may decrease oxygen to the RPE and photoreceptors and reduce clearance of waste products from Bruch's membrane, leading to its thickening with age. 13 Retinal hypoxia increases the release of VEGF within Ruysch's complex leading to CNV. 74 Vascular deficits are further advanced in AMD75 with a linear relationship between reduced choroidal blood flow and increased risk for development of CNV. 76 Retinal hypoxia drives the synthesis of VEGF, which gives rise to the angiogenesis seen in CNV. in people exposed to a risk factor to the odds of it occurring in people not exposed to a risk factor. The RR is a ratio of the probability of a disease occurring in a risk factor exposed group versus a non-exposed group. The hazard ratio (HR) is a ratio of the chance of events occurring in people exposed to a risk factor compared with people not exposed to a risk factor. Estimates of OR, RR or HR greater than 1.0 are statistically significant and suggest a positive association or increased risk of developing a disease. If described in the literature, statistically significant OR, RR and HR are reported in this article.
Modifiable Risk Factors
Smoking
Smoking is the one modifiable risk factor that has been largely consistently associated with an increased risk of developing ARMD.
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The Rotterdam study found that the higher the pack-years smoked, the higher the risk of developing neovascular AMD, with a 6.6-fold increase in risk for developing neovascular AMD compared with non-smokers. 87 The New Zealand morbidity and smoking prevalence data estimated that 26.8 % of all AMD cases were attributable to current and past smoking in New Zealand. 94 In the UK, a two-fold risk of ARMD has been associated with smoking when compared with non-smoking in 28,000 individuals (OR 2.15). 95 Cigar smoking in India has also been linked with a higher risk for developing AMD (OR 3.29). 96 A study of Latino subjects also demonstrated an association between smoking and AMD in the Hispanic population (OR 2.4). 97 The effects of passive smoking on AMD risk have been examined in a UK study comparing 435 people with end-stage AMD with 280 healthy controls. The results showed an OR of 1.87 in passive smoking exposure in non-smokers. 98 This prolific evidence across continents and differing ethnicities suggests that smoking is highly toxic to the retina, although the pathogenic mechanisms between smoking and retinal toxicity still remain unclear.
Risk Factors for Age-related Macular Degeneration
There are approximately 4,000 toxic components in cigarette smoke, one of which is nicotine. A study assessing the effects of nicotine on the vascular smooth muscle cells confirmed that nicotine increases CNV size and severity in laser-induced CNV in the mouse eye model. 99 Nicotine attaches to nicotinic acetylcholine receptors on photoreceptors, bipolar, horizontal and ganglion cells. 100 Tar within cigarette smoke contains hydroquinone -an oxidant that in the mouse eye has been shown to encourage sub-RPE deposits and thickening of Bruch's membrane. 101 Cadmium is another toxic oxidant found in cigarette smoke; higher urinary levels in smokers have been linked with an increased risk of AMD. 102 It accumulates at levels 2.5 times higher in the choroid-RPE complex of smokers compared with non-smokers 103 and increases reactive oxygen species, alters RPE cell morphology and decreases cell survival. 104 Studies on mice eyes have demonstrated that chronic exposure to smoke causes changes to the RPE similar to those observed in AMD, with RPE apoptosis, increased oxidative damage, 105 DNA damage to the RPE and increased inflammatory activity. 106 The effects of the combination of smoking and genetics of ARMD have been analysed in many studies. An additive effect of smoking for increased risk of developing ARMD has been shown when there is a genetic disposition for the disease.
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Alcohol Intake RRs were not provided in this study. 123 However, in another Brazilian study assessing AMD in two differing socioeconomic populations no association between AMD and socioeconomic background was seen (p=0.113). 124 No association was demonstrated between ARMD and socioeconomic factors in a case-control study by Hyman et al. 35 or in the Framingham eye study, 125 the Beaver Dam eye study 126 and the third National Health and Nutrition Examination Survey (NHANES) study. 127 Although the underlying reasons for increased risk of ARMD development with lower socioeconomic status have not been determined, possible mechanisms include the underuse of eye care services, poor nutrition and exposure to adverse work and home environments.
Education
The Age-related eye disease study (AREDS) report number three found that people with higher education had a lower risk for developing drusen (OR 0.73), GA (OR 0.45) and CNV (OR 0.44). 128 The Eye Disease
Case-Control Study Group (EDCCS) found a similar trend for education and neovascular AMD risk (OR 0.7 when 12 years of education or greater was completed compared with those who completed less than 12 years of education), although no statistical significance was demonstrated in their final multiple regression model. 78 The first NHANES study also demonstrated this association (OR 0.64) but statistical significance was lost on logistic regression modelling. 129 The mechanisms associating risk for ARMD development and educational level are not clear. People with lower educational level are more likely to be unemployed or in lower incomes jobs, leading to poorer socioeconomic status. Lower education may limit the ability to read and comprehend the importance of health literature.
Nutrition
Nutrition as an associated risk factor for developing ARMD has also been subject to conflicting findings in the literature. The first NHANES study found high levels of dietary vitamin A provides a protective effect against AMD (OR 0.74) with no beneficial effect shown with vitamin C. 129 The Beaver Dam eye study found no association between vitamins A, C and E and reduced risk of developing ARM. 130 Another study of serum lycopene in the Beaver Dam eye study
showed an increased risk of ARMD with reduced lycopene levels (OR 2.2). 131 However, lower levels of lutein, zeaxanthin and vitamin E were not related to an increased risk for ARMD development in this study. Conversely, higher serum alpha tocopherol was found to be conducive to lower ARMD risk in the Baltimore longitudinal study (OR 0.43). 132 The Physicians Health study and the Blue Mountains eye study did not find a protective effect for vitamin C, E and multivitamins 133 and vitamin E and beta carotene 134 against ARMD, respectively. The EDCCS found a 70 % reduced risk of AMD with high (>0.67 μmol/l) compared with low (0.25 μmol/l) levels of serum carotenoids. 135 A further study from the EDCCS reported that spinach and collards, high in the carotenoids lutein and zeaxanthin, were most strongly associated with a reduced risk for AMD (p<0.001).
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Collard greens are various loose-leafed vegetables of Brassica oleracea, the same species that produces cabbage and broccoli. 
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High levels of omega-3 fatty acid consumption (≥64.0 mg/day versus <26.0 mg/day) have been shown to provide a protective effect against progression to AMD (HR 0.73). 142 Lowering the dietary glycaemic index with higher omega-3 intake also showed a reduction in AMD progression in this study (p<0.001). The benefits of a low glycaemic diet in reducing ARM risk have been identified in other studies.
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The Blue Mountains eye study found a lower risk of developing ARM Posterior Segment Age-related Macular Degeneration 158 The RR was 2.35 for a BMI of 30 or more and 2.32 for a BMI of 25-29 for developing AMD in another study. 159 Larger waist circumference (RR 2.04) and a larger waist-hip ratio (RR 1.84) also increased the risk of progression to AMD. 159 An inverse relationship between BMI and retinal levels of L and Z (often referred to as macular pigment optical density) was reported. 160 The authors also assessed dietary L and Z intake and found that people with the highest BMI consumed lower amounts of L and Z. They concluded that lower dietary intake of L and Z, and/or competition between adipose tissue and retina for L and Z uptake were likely to affect retinal levels of L and Z. 160 Conversely, associations between lean men and dry AMD have been found. 161 A pooled study of 14,752 people from the Beaver Dam eye study, the Rotterdam study and the Blue Mountains eye study did not report any consistent association between BMI and risk for any forms of ARMD 92 and this was echoed in other studies.
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Cardiovascular Disease
Cardiovascular disease (CVD) has been associated with risk for developing ARMD in several studies and discounted in others. The
Beaver Dam eye study showed no association between CVD and neovascular AMD or GA. 163 Arterial stiffness -an indicator for CVD, has been shown to be associated with the presence of AMD. 164 The Blue
Mountains eye study did show associations between CVD (RR 1.57) for early incident ARM. 165 C-Reactive protein is an inflammatory marker for CVD. Some studies have shown increased levels of C-reactive protein in ARMD, [166] [167] [168] suggesting an inflammatory role in the development of ARMD. Conversely, better cardiovascular health was associated with an increased risk of ARMD in the Cardiovascular Health and Age-Related Maculopathy (CHARM) study (OR 2.54). 169 The POLA study showed a reduced risk (OR 0.72) for developing drusen and no association between AMD and a history of cardiovascular disease. 158 No association between CVD and ARMD risk was reported in the AREDS studies, 128,157 the EDCCS study 78 35 in an earlier study but not in a later study. 170 Hyman et al. also found an association between moderate to severe hypertension (diastolic >95 mmHg) and risk for developing neovascular AMD (OR 4.4), especially in people receiving antihypertensive medication. 170 The same association was not found for GA and hypertension, leading the authors to suggest that comparable disease processes may occur in neovascular AMD and hypertension. 170 Reduced choroidal blood flow in people with hypertension with neovascular AMD may account for this relationship. 171 The Framingham eye study 125 and the first NHANES study (OR 1.5 for systolic blood pressure≥170 mmHg) 129 reported links between ARMD development risk and hypertension. The AREDS group found increased risk for developing neovascular AMD (OR 175, 176 found no evidence to suggest that ARMD development risk and hypertension are linked.
Cholesterol Levels and Treatment
Links between cholesterol levels, cholesterol-lowering treatments and risk of ARMD development have been conflicting. A possible protective effect of statins and lipid-lowering treatments against ARMD has been found in a number of studies (OR 0.14-0.79).
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Some studies have suggested statins protect the vascular endothelium from oxidative damage 182 Risk Factors for Age-related Macular Degeneration
as possible mechanisms for increasing AMD risk after cataract extraction. 226 Other studies, such as the AREDS group report 25, found no risk of ARMD progression after cataract surgery. 227, 228 It has been postulated that the cataract itself increases the risk of developing ARMD. In pooled findings from three studies severe cataract was associated with a higher prevalence of AMD, although this was not statistically significant. 229 Studies assessing the risk of ARMD development associated with the use of newer intraocular lenses with short-wavelength blue light filtering properties may provide more information in the coming years.
Cognitive Impairment
Evidence from the AREDS group showed a trend between reduced cognitive impairment and increased risk of AMD development (p<0.01
for a mental state examination and 0.048 for a logical memory test). 230 This was resonated in people with ARM in the Cardiovascular Health Study (OR 1.38), 231 a weak association in another study (OR 1.6 for ARM) 232 and in people with AMD in an Australian population (OR 2.2). 233 The Rotterdam study demonstrated that tobacco and atherosclerosis may play a role in the pathogenesis of both ARMD and Alzheimer's disease. 234 Amyloid beta peptide is found in the neuritic plaques in
Alzheimer's disease and also in drusen. It contributes to inflammatory processes in both of these diseases 235 and in many neurodegenerative diseases of ageing such as Parkinson's disease, arthritis, atherosclerosis and myocardial infarction. 236 Many people with ARMD reduce their physical and mental activity levels, which is associated with cognitive decline. 237 Conversely, no significant relationship was established between Alzheimer's disease and ARMD 238 in 33 people with Alzheimer's disease compared with 24 controls. The authors believe that a small sample size and age differences between the groups may have accounted for the lack of any relationship. They did not specify between ARM or AMD for their study.
Gender
Female gender has been associated with increased risk for development of ARMD, although no consensus seems to prevail. A Croatian study of 6,617 patients found that ARMD incidence was slightly increased in women compared with men (56 versus 46 %). 5 This was echoed by the AREDS group, with ARM being more apparent in women (OR 1.22) 128 and in other work (no OR, RR or HR reported). 216 However this was not replicated in a pooled analysis from the Beaver Dam, Rotterdam and Blue Mountains Eye studies. 92, 239 Men were more likely to undergo photodynamic therapy than women for neovascular AMD in an Israeli study (0.21 versus 0.16 %, p=0.03)240 and were more likely to have AMD than women in two Japanese studies (statistical significance was not reached in one of the studies, but the other having an OR of 2.97). 241 , 242 The authors suggest that this may be due to the significantly higher proportion of Japanese men who smoke. A recent study of the Beaver Dam offspring study also showed that being male was associated with ARM (OR 1.65).
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Arthritis
An association between arthritis and increased likelihood of ARM was reported in one AREDS study (OR 1.26), 128 whereas another AREDS study suggested a protective effect of anti-inflammatory medications against AMD development (OR 0.22). 157 One study found people with rheumatoid arthritis had less prevalence of AMD and suggested anti-inflammatory agents, commonly used to manage the symptoms of rheumatoid arthritis, provide a protective effect against development of ARMD, 243 since there is some evidence that inflammation may play a role in the development of ARMD. 244 However, environmental and genetic factors may also be relevant as rheumatoid arthritis is commonly a disease of the young and ARMD is more apparent over 50 years of age. 245 
Ethnicity
Higher prevalence of ARMD has been shown in white people compared with black people, although genetics, culture and diet may play a role in these differences. Darker iris pigmentation may also confer some protective effect in the black population. 246 The AREDS group found a higher risk of developing large drusen (OR 1.88) and CNV (OR 4.22) in white people. 128 A further AREDS study echoed these results for incident CNV (OR 6.77). 157 However, no such association was found in a Brazilian study of 107 people with ARMD. 124 In the Salisbury Eye Evaluation project the risk of developing large drusen (OR 2.10) and RPE pigmentation (OR 2.22) was higher in white people than in black people but the risk of developing GA or CNV was no different for white and black people. 247 A south Indian study found a prevalence of AMD in its population similar to other developed countries. 96 A Japanese population study reported similar prevalence of ARM to the white population of the Blue Mountains eye study.
This similarity also held true for AMD in Japanese men, but AMD prevalence was lower in Japanese women compared with the Blue
Mountains Eye Study population. This disparity was assumed to occur because of a high proportion of Japanese male smokers according to the authors. 241 Another Japanese study compared the incidence of ARMD in the Japanese population with the Beaver Dam eye study, the Blue Mountains eye study (both with a predominantly white population) and the Barbados eye study (a predominantly black population). 242 The authors concluded that the nine-year incidence of ARMD was lower among the Japanese population than among white people, but AMD was higher in the Japanese population than among black people. The prevalence of ARM in South Koreans was also found to be similar to other studies but the prevalence of AMD was lower. 221 Exudative AMD was found to be higher in Chinese people (OR 4.3) compared with white people in a study assessing four different ethnic groups, even when smoking age, gender, pupil size, BMI, alcohol intake, diabetes and hypertension were adjusted for. 248 A putative mechanism for reduced risk of ARMD in black people compared with white people is the protective effect of the darker pigmentation of the iris 246 and higher concentrations of melanin within the choroid of black people compared with white people. 249 Melanin acts as an antioxidant, scavenging free radicals and reducing oxidative stress. 24 
Iris Pigmentation
Iris pigmentation has been inconsistently associated with an increased risk for ARMD with the EDCCS demonstrating no association between iris colour and neovascular AMD, 78, 250 incident ARMD 251 or GA. 250 Conversely light irises were associated with increased risk for ARMD in other studies (OR 1.22-5.0). 218, 252, 253 Blue iris colour was linked with increased risk of both ARM and AMD in the Blue Mountains eye study (OR 1.69). 254 However, five years later, longitudinal data did not support this association. A study of 1,000 Danes also showed no difference between light iris and dark iris colour for AMD. 255 
Hypermetropia
Hypermetropia and its associated shorter axial length have been linked with increased ARMD development risk 35, [256] [257] [258] [259] [260] (in these studies, either p<0.05 or OR 1.54-2.4, depending on the statistics used). An association
Posterior Segment Age-related Macular Degeneration with ARMD. 178 Aspirin was not found to be related to an increased risk of ARM or AMD development in the AREDS study, 128 but was positively correlated in a later AREDS study (OR 1.88). 157 It was not linked in other studies [190] [191] [192] or its effects were not reported. 
Hormones
The use of differing hormones has been associated with risk for developing ARMD. Thyroid hormones were associated with an increased risk of GA in the AREDS study (OR 1.99), although the use of oestrogen and progesterone in women was not associated with any form of ARMD in this study. 128 Thyroid and antithyroid hormones were not associated with ARMD in another study. 193 There was also no association between the use of hormone replacement therapy (HRT), hysterectomy or oopherectomy in women and ARMD risk in the POLA study. 195 However, a protective effect of HRT was found in another study, with a 48 % lower risk of developing CNV compared with women who had never used HRT, although no protective effect was found for ARM. 196 A reduced risk of developing ARM was seen in another study in women taking HRT (OR 0.6). 194 A lack of oestrogen was shown to be associated with an increase in basal laminar deposits and thickened Bruch's membranes in mice retinae. 197 The authors postulated that oestrogen downregulated matrix metalloproteinase-2, which is 155 or reported by others. 78 , 92 The mechanisms for any association between diabetes and ARMD are unknown.
Hyperglycaemia in diabetes has been associated with reduced choroidal circulation within the foveal area. 202, 203 This may reduce the exchange of oxygen, nutrients and waste products within the outer retina, which may increase susceptibility to ARMD.
Sunlight Exposure
There are contradictory findings in the literature about the relationship between exposure to sunlight and risk for ARMD development. No statistically significant associations were reported in a Brazilian study, 124 an Italian study 204 or studies from other global locations. 78, 128, 205, 206 Intriguingly, two studies demonstrated a protective effect of light against ARMD (OR 0.73 in one study and annual sun exposure of controls at 940 versus 770 hours in those with ARMD, p=0.0002). 207, 208 However, other studies have shown a detrimental effect of sunlight with increased risk of ARMD development. Blue light exposure was associated with an increased risk of developing GA in a study of 838 watermen (OR 1.36). 209 The Beaver Dam eye study found a relationship between high sunlight exposure and a higher 10-year incidence of ARM 
Non-modifiable Risk Factors
It is well reported that increasing age is strongly linked with a higher risk of developing ARMD 92, 96, 128, 204, [215] [216] [217] [218] [219] [220] [221] and certain genes have been recognised for their association with disease development, but there are other non-modifiable risk factors for developing the disease that are inconsistent in the literature.
Cataracts and Intraocular Lenses
Cataracts are known to protect the retina by reducing the amount of ultraviolet and blue light entering the eye. Thus, after cataract extraction, the retina is subjected to increased light levels and increased photochemical damage. The Blue Mountains eye study and the Beaver Dam eye study found an increased risk for developing ARMD in eyes that had undergone cataract surgery (OR 1.3-5.7 in these studies). [222] [223] [224] or HR given). 35, 125 Unusual optic disc appearance has been associated with ARMD risk (no risk statistics reported) 265 but repealed in other studies. 266, 267 Babies with increased birth weight were found to have a higher possibility of developing AMD than those with lower birth weight in one study (OR 1.5) 268 and this was echoed in another study, but only in white people for ARM (OR 1.2), although AMD risk was not assessed in this study.
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Summary
There are many risk factors associated with ARMD development, with varying degrees of consistency. Age, smoking and genetics appear to be congruously linked with increased risk for developing the disease.
With the costly management of neovascular AMD and limited treatment for dry AMD, the potential for modification of environmental factors in reducing the risk of ARMD development is an important research area. The oxidative stress theory for the aetiology of ARMD provokes interest in how antioxidants may play a role in reducing the risk of disease development and progression. n
